3137 results for «933»
3137 results
Interventions on Pulmonary Embolism: The Next Big Thing?
15 May 2023 – From PCR Innovators Day 2023
What else will become the "Next Big Thing" in Coronary Artery Disease, Peripheral Vascular, treatment of Hypertension or Cardiovascular Imaging for the Interventional Cardiologist?
15 May 2023 – From PCR Innovators Day 2023
Feedback from Innovator's Exchange Hub
15 May 2023 – From PCR Innovators Day 2023
Tips and tricks in valvular intervention
19 Feb 2023 – From PCR Tokyo Valves 2023
In this session, unlock advanced valvular intervention insights (in Japanese). Overcome challenges like aortic valve alignment failure, cardiogenic shock with LMTD and AS and unforseen low atrial septal puncture for successful, optimised procedures.
Selection of the 2023 best clinical cases
19 Feb 2023 – From PCR Tokyo Valves 2023
Explore the most outstanding clinical cases from PCR Tokyo Valves 2023, including a delayed left ventricular rupture after transcatheter edge-to-edge mitral valve repair and successful bailouts in transcatheter mitral valve repair.
Challenging case in mitral valve intervention
19 Feb 2023 – From PCR Tokyo Valves 2023
Consult this session to discover challenging mitral valve cases. Learn to anticipate challenging anatomy, determine optimal timing for MitraClip, and witness changes in degenerative and functional mitral regurgitation procedures.
Selection of the 2023 best abstracts
19 Feb 2023 – From PCR Tokyo Valves 2023
Watch this session to discover the best cases and abstracts unveiled at PCR Tokyo Valves 2023, covering topics such as transcatheter aortic valve implantation impact, cerebral protection efficacy, and post-TAVI aortic regurgitation quantification.
Abstracts - Coronary interventions - Session 4
07 Oct 2022 – From AICT-AsiaPCR 2022
Future perspectives of LAAC
17 Feb 2023 – From PCR Tokyo Valves 2023
In this session, delve into the evolving landscape of Left Atrial Appendage Closure (LAAC). Explore evidence, optimal patient criteria, and comprehensive preprocedural assessments for innovative LAAO devices.
Clinical cases - Structural interventions - Session 7
07 Oct 2022 – From AICT-AsiaPCR 2022
Management of challenging TAVI device delivery
22 May 2025 – From EuroPCR 2025
Explore innovative solutions for managing challenging TAVI device delivery. This session presents cases involving kinked and stuck Navitor valves, the use of snare devices for retrieval, balloon-expandable TAVI in severe bicuspid aortic stenosis, and alternative access routes such as transaortic access after failed transfemoral valve-in-valve procedures.
When angina cannot be cured with stents: what are the remaining options
22 May 2025 – From EuroPCR 2025
Explore therapeutic options for patients with angina refractory to stenting. This session reviews the efficacy and clinical outcomes of coronary sinus (CS) reducer implantation for microvascular dysfunction, factors influencing procedural success, next-generation CS reducer innovations, and the role of aspirin in angina without obstructive coronary disease.
A central role for cardiac imaging in transcatheter LAA closure
22 May 2025 – From EuroPCR 2025
Discover the central role of cardiac imaging in transcatheter left atrial appendage (LAA) closure. This session covers sealing techniques, advances in cardiac tomography for assessing LAA wall thickness, fusion of 3D computational modeling with fluoroscopy guidance, device healing evaluation through early serial imaging, and complex cases...
TAVI - Outcomes predictors
22 May 2025 – From EuroPCR 2025
Examine novel predictors of outcomes following TAVI. This session compares a new nutritional risk index against traditional scores for early post-TAVI mortality prediction and evaluates uric acid as a marker for aortic valve calcification and mortality risk in TAVI patients.
Optimal acute heart failure care: must have, must do
22 May 2025 – From EuroPCR 2025
This session presents must-have strategies for optimal acute heart failure care. Topics include establishing an extracorporeal cardiopulmonary resuscitation referral center with patient outcomes, percutaneous closure in ventricular septal rupture, modified manual compression for large-bore sheaths, antithrombotic therapy considerations in AMI complicated by cardiogenic shock with mechanical...
Beyond the intervention: outcomes of CTO PCI
22 May 2025 – From EuroPCR 2025
Discover long-term outcomes and practical insights into chronic total occlusion (CTO) PCI. This session presents real-world registry data, cost-effectiveness analyses, effects of successful revascularisation in reduced ejection fraction and heart failure patients, and specific outcomes in octogenarian populations.
TAVI for aortic regurgitation off label
22 May 2025 – From EuroPCR 2025
Explore off-label applications of TAVI for aortic regurgitation in complex clinical scenarios. Topics include TAV-in-SAV with Trilogy valve for severe regurgitation, challenges of transcatheter prosthesis in pure aortic regurgitation, management of surgical valve perforations, and treatment strategies in post-surgical anatomies including degenerative homografts and aortic dissection.
Retrograde removal of the broken sheath
22 May 2025 – From EuroPCR 2025
This session addresses complex complications during vascular access with a focus on retrograde removal of broken sheaths. Learn to recognize critical signs, manage rare but severe complications including broken guidewires in the radial artery, and explore innovative off-label solutions for challenging scenarios.
Optimal SCAD treatment
22 May 2025 – From EuroPCR 2025
Navigate the complexities of spontaneous coronary artery dissection (SCAD) treatment through clinical case discussions. This session explores identifying the culprit lesion, recurrent ACS challenges, the conservative versus PCI treatment dilemma, and real-world presentation scenarios emphasizing decision-making in SCAD management.
Acute complications during distal left main PCI - Part 3
22 May 2025 – From EuroPCR 2025
This session highlights acute complications during distal left main PCI. It presents cautionary cases of incorrect left main stenting, catastrophic left main V stenting outcomes, unprotected left main thrombosis, and survival strategies when new technologies fail unexpectedly.
